ArticlePharmaceuticals (Basel, Switzerland)2025

Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target.

Muhammad Suleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.